Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid Leukemia

NCT05522192 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Relapsed or Refractory Acute Myeloid Leukemia

Interventions

DRUG: Mitoxantrone liposome
DRUG: Venetoclax

Sponsor

Hui Zeng

Collaborators

[object Object]